Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

247 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.
Foster GR, Goldin RD, Thomas HC. Foster GR, et al. Hepatology. 1998 Jan;27(1):209-12. doi: 10.1002/hep.510270132. Hepatology. 1998. PMID: 9425939
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III).
Shafran SD, Shaw D, Charafeddine M, Agarwal K, Foster GR, Abunimeh M, Pilot-Matias T, Pothacamury RK, Fu B, Cohen E, Cohen DE, Gane E. Shafran SD, et al. Among authors: foster gr. J Viral Hepat. 2018 Feb;25(2):118-125. doi: 10.1111/jvh.12782. Epub 2017 Sep 14. J Viral Hepat. 2018. PMID: 28833938 Clinical Trial.
Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.
Shoeb D, Dearden J, Weatherall A, Bargery C, Moreea S, Alam S, White E, Vila X, Freshwater D, Ryder S, Mills PR, Alexander GJ, Forton D, Foster GR. Shoeb D, et al. Among authors: foster gr. J Hepatol. 2014 Apr;60(4):699-705. doi: 10.1016/j.jhep.2013.11.011. Epub 2013 Nov 26. J Hepatol. 2014. PMID: 24291239 Clinical Trial.
Hepatitis C virus infection: quality of life and side effects of treatment.
Foster GR. Foster GR. J Hepatol. 1999;31 Suppl 1:250-4. doi: 10.1016/s0168-8278(99)80411-5. J Hepatol. 1999. PMID: 10622597 Review.
Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy.
Thomas HC, Török ME, Foster GR. Thomas HC, et al. Among authors: foster gr. Hepatology. 1999 Apr;29(4):1333-4. doi: 10.1002/hep.510290453. Hepatology. 1999. PMID: 10094985 No abstract available.
Management of chronic hepatitis C: clinical audit of biopsy based management algorithm.
Foster GR, Goldin RD, Main J, Murray-Lyon I, Hargreaves S, Thomas HC. Foster GR, et al. BMJ. 1997 Aug 23;315(7106):453-8. doi: 10.1136/bmj.315.7106.453. BMJ. 1997. PMID: 9284661 Free PMC article.
Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.
Booth JC, Foster GR, Kumar U, Galassini R, Goldin RD, Brown JL, Thomas HC. Booth JC, et al. Among authors: foster gr. Gut. 1995 Mar;36(3):427-32. doi: 10.1136/gut.36.3.427. Gut. 1995. PMID: 7698703 Free PMC article. Clinical Trial.
Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy.
Foster GR, Goldin RD, Hay A, McGarvey MJ, Stark GR, Thomas HC. Foster GR, et al. Hepatology. 1993 May;17(5):757-62. Hepatology. 1993. PMID: 7684016
Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response.
Foster GR, Thomas HC. Foster GR, et al. Gut. 1993 Jan;34(1):1-3. doi: 10.1136/gut.34.1.1. Gut. 1993. PMID: 7679364 Free PMC article. Review. No abstract available.
Effects of hepatitis B and hepatitis C virus replication on the actions of interferon.
Foster GR, Thomas HC. Foster GR, et al. Antiviral Res. 1994 Jul;24(2-3):131-6. doi: 10.1016/0166-3542(94)90061-2. Antiviral Res. 1994. PMID: 7526787 Review.
247 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page